Introduction
A whole series of new drugs has become available for the treatment of certain forms of psychiatric illness and the interest they have evoked is reflected in the hundreds of publications on their use and action and in the pharmaceutical research which continually adds some new compound to the already formidable list of tranquillizers. These drugs are characterized by their ability to produce sedation without hypnosis and Fabing (I955a) has suggested the term ' ataraxy' to denote the peace of mind and freedom from mental disturbance which it is claimed they produce.
Although the indications for the use of reserpine and chlorpromazine, which have been in largescale use for three or four years, are becoming clearer, the position with regard to the newer tranquillizers is by no means certain, and it seems appropriate to make some critical review of the information at present available concerning the mode of action and clinical uses of these drugs.
Site and Mode of Action
Research on the neurophysiological action of chlorpromazine and reserpine has been summarized by Hinwich (1955) . It seems that these drugs exert a central action on the hypothalamus and also on the mesendiencephalic alerting system (Rinaldi and Himwich, I955) which comprises the reticular formation of Moruzzi and Magoun (1949) and the thalamic diffuse cortical projections of Jasper (I949) . By depressing the hypothalamus they lower basal metabolism, body temperature and blood pressure and they also influence the anterior pituitary, causing disturbance of hormonal balance, which leads to lactation and amenorrhea in some women. In general, they thus produce parasympathomimetic effects and, in addition, chlorpromazine has a peripheral blocking action on sympathetic ganglia. (Gaddum, 1953) . It is suggested (Wooley and Shaw, I954a, b) that serotonin concentration influences the development of some mental disorders. The precise mechanism is still undetermined, but it seems possible that tranquillizing drugs may alter behaviour by their influence on serotonin ).
Classification
The tranquillizing drugs are difficult to classify by chemical structure, although phenothiazine derivatives form a homogeneous group. Their neurophysiological properties might be used as a basis for grouping, but at present it seems best to follow a clinical classification as suggested by Lieberman and Vaughan (1956 (Labhardt, 1954; Lomas, 1955) consider that it alters the content of schizophrenic psychosis, and in some hospitals it has replaced insulin as a method of treatment of schizophrenia (Boardman et al., 1956; Bowes, 1956 Barsa and Kline, I956b) have failed to show that it has any therapeutic effect. Sargant (1956) suggests that frenquel may be of use in some cases of intractable depression when combined with E.C.T. All authors agree on the absence of toxicity and side-effects.
Less Powerful Tranquillizers
Meprobamate acts on the central nervous system only without affecting autonomic functions. Its main effect seems to be the alleviation of anxiety and tension, and it also functions as a muscle relaxant. In America, under the name of ' Miltown,' it enjoys a tremendous vogue as a tranquillizer and encouraging reports of its use in neurotic patients have been summarized by Berger (I956). It is suggested that meprobamate is more effective than barbiturates in the relief of anxiety and tension (Borrus, 1955; Selling, I955) , but this is not supported by West and da Fonseca (I956), who found no marked difference in a controlled trial. It appears that considerable care is necessary in selection of cases, as in some individuals tension is actually increased (Folkson, 1957) . Early reports stressed the low toxicity of meprobamate, but this has recently been refuted (Brit. med. 7., 1956) . Skin lesions, sometimes of a purpuric nature, are known to occur, while drowsiness may be a serious matter in patients driving a car. The sense of euphoria produced in some patients may encourage addiction and overdosage, with signs of intoxication, dysarthria and inco-ordination, and withdrawal after large doses may lead to convulsions (Lemere, 1956) .
Benactyzine has anti-cholinergic properties and is believed to block certain afferent pathways, thus protecting higher centres of the brain against external stress. It is said to be of benefit in the relief of anxiety and tension (e.g. Davies, I956) . Some workers, however, state that benactyzine has no advantage over inert tablets (Forbes and Earle, 1957) and the favourable conclusions drawn from a controlled trial by Hargreaves et al. (1957) have been severely criticized by Hare (I957) and Taylor (1957) . General anticipated.
Conclusion
The phenothiazine tranquillizers and reserpine are valuable drugs in psychotic illness, particularly in the management and control of over-active aggressive behaviour and the confusion and excitement of the acutely disturbed patient. There is as yet little evidence that they influence the underlying psychotic process.
Certain drugs, notably chlorpromazine and meprobamate, appear to reduce tension in neurotic patients, but, in general, the effect of current tranquillizers on these patients is disappointing and barbiturates are probably as effective in controlling symptoms.
The toxic reactions produced by tranquillizing drugs vary in severity, but it is wise to regard all as potentially dangerous, certainly during the early stages of their introduction.
As with most new drugs, initial assessments of the value of tranquillizers have tended to be overrated. Uncritical enthusiasm harbours dangers as well as disappointments and in many cases proper evaluation of these drugs must be deferred pending adequate clinical experience.
